Skip to main content
Erschienen in: Pediatric Cardiology 3/2008

01.05.2008 | Original Article

Relation of Left Ventricular Hypertrophy to Microalbuminuria and C-Reactive Protein in Children and Adolescents with Essential Hypertension

verfasst von: Farahnak Assadi

Erschienen in: Pediatric Cardiology | Ausgabe 3/2008

Einloggen, um Zugang zu erhalten

Abstract

Microalbuminuria (MA) and C-reactive protein (CRP) levels are predictors of increased risk for left ventricular hypertrophy (LVH). Whether the strength of association between CRP and LVH is comparable to that of MA in hypertensive children is unknown. CRP and MA were measured in 64 children and adolescents with essential hypertension (HTN). In the entire population, CRP and MA showed positive relations with body mass index (BMI) (r = 0.30, p = 0.04 and r = 0.32, p = 0.04, respectively), systolic blood pressure (SBP) (r = 0.63, p = 0.03 and r = 0.58, p = 0.03, respectively), and LVH (r = 0.86, p < 0.001 and r = 0.81, p < 0.001, respectively). Patients with LVH (n = 23) had significantly higher BMI (p = 0.32), increased SBP (p = 0.031), and higher levels of CRP (p < 0.001) and MA (p < 0.001) compared with those without LVH. Multiple linear regression analysis demonstrated that CRP (r = 2.11, p < 0.001), MA (r = 1.94, p < 0.003), BMI (r = 0.53, p = 0.02), and SBP (r = 0.48, p = 0.04) were significantly associated with LVH. By analysis of covariance, CRP and MA were significantly different between patients who had LVH and those without LVH after adjustment for age, gender, BMI, SBP, SBP index, and diastolic blood pressure (p < 0.001 for the two markers). In conclusion, the strength of association between LVH and CRP is comparable to that of MA in children and adolescents with essential HTN.
Literatur
1.
Zurück zum Zitat Assadi F (2002) Quantitation of microalbuminuria using random urine samples. Pediatr Nephrol 17:107–110PubMedCrossRef Assadi F (2002) Quantitation of microalbuminuria using random urine samples. Pediatr Nephrol 17:107–110PubMedCrossRef
2.
Zurück zum Zitat Assadi F (2006) Effect of microalbuminuria-lowering on regression of left ventricular hypertrophy in children and adolescents with essential hypertension. Pediatric Cardiol 28:27–33CrossRef Assadi F (2006) Effect of microalbuminuria-lowering on regression of left ventricular hypertrophy in children and adolescents with essential hypertension. Pediatric Cardiol 28:27–33CrossRef
3.
Zurück zum Zitat Assadi F (2007) C-reactive protein and incident left ventricular hypertrophy in essential hypertension. Pediatr Cardiol 28:280–285PubMedCrossRef Assadi F (2007) C-reactive protein and incident left ventricular hypertrophy in essential hypertension. Pediatr Cardiol 28:280–285PubMedCrossRef
4.
Zurück zum Zitat Briars GL, Bailey BG (1994) Surface area estimation: pocket calculator versus nomogram. Arch Dis Child 70:246–247PubMedCrossRef Briars GL, Bailey BG (1994) Surface area estimation: pocket calculator versus nomogram. Arch Dis Child 70:246–247PubMedCrossRef
5.
Zurück zum Zitat Cole Tj, Bellizzi MC, Flegal KM, Dietz WH (2000) Establishing a standard definition for child overweight and obesity worldwide: international survey. Br Med J 320:1240–1243CrossRef Cole Tj, Bellizzi MC, Flegal KM, Dietz WH (2000) Establishing a standard definition for child overweight and obesity worldwide: international survey. Br Med J 320:1240–1243CrossRef
6.
Zurück zum Zitat Daniels SR, Loggie JM, Khoury P, Kimball TR (1998) Left ventricular geometry and severe left ventricular hypertrophy in children and adolescents with essential hypertension. Circulation 97:1907–1911PubMed Daniels SR, Loggie JM, Khoury P, Kimball TR (1998) Left ventricular geometry and severe left ventricular hypertrophy in children and adolescents with essential hypertension. Circulation 97:1907–1911PubMed
7.
Zurück zum Zitat Daniels SR, Kimball TR, Morrison JA, Khoury P, Meyer RA (1995) Indexing left ventricular mass to account for differences in body size in children and adolescents without cardiovascular disease. Am J Cardiol 76:699–701PubMedCrossRef Daniels SR, Kimball TR, Morrison JA, Khoury P, Meyer RA (1995) Indexing left ventricular mass to account for differences in body size in children and adolescents without cardiovascular disease. Am J Cardiol 76:699–701PubMedCrossRef
8.
Zurück zum Zitat Daniels SR, Kimball TR, Morrison JA, Khoury P, Witt S, Meyer RA (1995) Effect of lean body mass, fat mass, blood pressure, and sexual maturation on left ventricular mass in children and adolescents: Statistical, biological, and clinical significance. Circulation 92:3249–3254PubMed Daniels SR, Kimball TR, Morrison JA, Khoury P, Witt S, Meyer RA (1995) Effect of lean body mass, fat mass, blood pressure, and sexual maturation on left ventricular mass in children and adolescents: Statistical, biological, and clinical significance. Circulation 92:3249–3254PubMed
9.
Zurück zum Zitat Devereux RB, Alonso DR, Lutas EM, et al. (1986) Echocardiographic assessment of left ventricular hypertrophy: comparison to necroscopy findings. Am J Cardiol 57:450–458PubMedCrossRef Devereux RB, Alonso DR, Lutas EM, et al. (1986) Echocardiographic assessment of left ventricular hypertrophy: comparison to necroscopy findings. Am J Cardiol 57:450–458PubMedCrossRef
10.
Zurück zum Zitat de Simone G, Daniels SR, Devereux RB, et al. (1992) Left ventricular mass and body size in normotensive children and adults: assessment of allometric relations and impact of overweight. J Am Coll Cardiol 20:1251–1260PubMedCrossRef de Simone G, Daniels SR, Devereux RB, et al. (1992) Left ventricular mass and body size in normotensive children and adults: assessment of allometric relations and impact of overweight. J Am Coll Cardiol 20:1251–1260PubMedCrossRef
11.
Zurück zum Zitat de Simone G, Devereux RB, Daniels SR, Koren MJ, Meyer RA, Laragh JH (1995) Effect of growth on variability of left ventricular mass: assessment of allometric signals in adults and children and their capacity to predict cardiovascular risk. J Am Coll Cardiol 25:1056–1062PubMedCrossRef de Simone G, Devereux RB, Daniels SR, Koren MJ, Meyer RA, Laragh JH (1995) Effect of growth on variability of left ventricular mass: assessment of allometric signals in adults and children and their capacity to predict cardiovascular risk. J Am Coll Cardiol 25:1056–1062PubMedCrossRef
12.
Zurück zum Zitat De Zeeuw (2004) Albuminuria, not only a cardiovascular/renal risk marker, but also a target for treatment? Kidney Int 66(Suppl 92):S2–S6 De Zeeuw (2004) Albuminuria, not only a cardiovascular/renal risk marker, but also a target for treatment? Kidney Int 66(Suppl 92):S2–S6
13.
Zurück zum Zitat Festa A, D’Agostino R, Howard G, Mykkanen L, Tracy RP, Haffner SM (2000) Inflammation and microalbuminuria in non diabetic and type 2 diabetic subjects: the insulin resistance atherosclerosis study. Kidney Int 58:1703–1710PubMedCrossRef Festa A, D’Agostino R, Howard G, Mykkanen L, Tracy RP, Haffner SM (2000) Inflammation and microalbuminuria in non diabetic and type 2 diabetic subjects: the insulin resistance atherosclerosis study. Kidney Int 58:1703–1710PubMedCrossRef
14.
Zurück zum Zitat Grandi AM, Santillo R, Bertolini A, et al. (2001) Microalbuminuria as a marker of preclinical diastolic dysfunction in never treated essential hypertensives. Am J Hypertens 14:644–648PubMedCrossRef Grandi AM, Santillo R, Bertolini A, et al. (2001) Microalbuminuria as a marker of preclinical diastolic dysfunction in never treated essential hypertensives. Am J Hypertens 14:644–648PubMedCrossRef
15.
Zurück zum Zitat Herbert LA, Wilmer WA, Falkenhain ME, Ladson-Wofford SE, Nahman NS Jr, Rovin BH (2001) Renoprotection: one or many therapies? Kidney Int 59:1211–1226CrossRef Herbert LA, Wilmer WA, Falkenhain ME, Ladson-Wofford SE, Nahman NS Jr, Rovin BH (2001) Renoprotection: one or many therapies? Kidney Int 59:1211–1226CrossRef
16.
Zurück zum Zitat Jensen JS, Feldt-Rasmussen BO, Strandgaard S, Schroll M, Borch-Johnson K (2000) Arterial hypertension, microalbuminuria, and risk of ischemic heart disease. Hypertension 35:898–903PubMed Jensen JS, Feldt-Rasmussen BO, Strandgaard S, Schroll M, Borch-Johnson K (2000) Arterial hypertension, microalbuminuria, and risk of ischemic heart disease. Hypertension 35:898–903PubMed
17.
Zurück zum Zitat Keane WF, Eknoyan G (1999) Proteinuria, albuminuria, risk, assessment, detection, elimination (PARADE): a position paper of the National Kidney Foundation. Am J Kidney Dis 33:1004–1110PubMedCrossRef Keane WF, Eknoyan G (1999) Proteinuria, albuminuria, risk, assessment, detection, elimination (PARADE): a position paper of the National Kidney Foundation. Am J Kidney Dis 33:1004–1110PubMedCrossRef
18.
Zurück zum Zitat Litwin M, Niemirska A, Sladowska J, et al. (2006) Left ventricular hypertrophy and arterial wall thickening in children with essential hypertension. Pediatr Nephrol 21:811–819PubMedCrossRef Litwin M, Niemirska A, Sladowska J, et al. (2006) Left ventricular hypertrophy and arterial wall thickening in children with essential hypertension. Pediatr Nephrol 21:811–819PubMedCrossRef
19.
Zurück zum Zitat Mattman A, Eintracht S, Mock T, et al. (2006) Estimating pediatric glomerular filtration rates in the era of chronic kidney disease staging. J Am Soc Nephrol 17:485–496CrossRef Mattman A, Eintracht S, Mock T, et al. (2006) Estimating pediatric glomerular filtration rates in the era of chronic kidney disease staging. J Am Soc Nephrol 17:485–496CrossRef
20.
Zurück zum Zitat Nakamura M, Onoda T, Itai K, et al.A (2004) Association between serum C-reactive protein levels and microalbuminuria: a population-based cross-sectional study in northern Iwate, Japan. Int Med 43:919–925CrossRef Nakamura M, Onoda T, Itai K, et al.A (2004) Association between serum C-reactive protein levels and microalbuminuria: a population-based cross-sectional study in northern Iwate, Japan. Int Med 43:919–925CrossRef
21.
Zurück zum Zitat National High Blood Pressure Education Program Working Group on High Blood Pressure in Children, Adolescents (2004) The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 114:555–576CrossRef National High Blood Pressure Education Program Working Group on High Blood Pressure in Children, Adolescents (2004) The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 114:555–576CrossRef
22.
Zurück zum Zitat Ogden CL, Kuczmarski RJ, Flegal KM, Mei Z, Guo S, Wei R (2002) Centers for Disease Control and Prevention 2000 growth charts for the united States: improvements to the 1977 National Center for Health Statistics version. Pediatrics 109:45–60PubMedCrossRef Ogden CL, Kuczmarski RJ, Flegal KM, Mei Z, Guo S, Wei R (2002) Centers for Disease Control and Prevention 2000 growth charts for the united States: improvements to the 1977 National Center for Health Statistics version. Pediatrics 109:45–60PubMedCrossRef
23.
Zurück zum Zitat Pannacciulli N, Cantatore FP, Minenna M, Bellacicco M, Giorgino R, De Pergola G (2001) Urinary albumin excretion is independently associated with C-reactive protein levels in overweight and obese nondiabetic premenopausal women. J Int Med 250:502–507CrossRef Pannacciulli N, Cantatore FP, Minenna M, Bellacicco M, Giorgino R, De Pergola G (2001) Urinary albumin excretion is independently associated with C-reactive protein levels in overweight and obese nondiabetic premenopausal women. J Int Med 250:502–507CrossRef
24.
Zurück zum Zitat Ridker PM (2001) High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease. Circulation 103:1813–1818PubMed Ridker PM (2001) High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease. Circulation 103:1813–1818PubMed
25.
Zurück zum Zitat Ramaswamy P, Lytrivi ID, Paul C, Golden M, Kupferman JC (2007) Regression of left ventricular hypertrophy in children with antihypertensive therapy. Pediatr Nephrol 22:141–143PubMedCrossRef Ramaswamy P, Lytrivi ID, Paul C, Golden M, Kupferman JC (2007) Regression of left ventricular hypertrophy in children with antihypertensive therapy. Pediatr Nephrol 22:141–143PubMedCrossRef
26.
Zurück zum Zitat Ridker PM, Cannon CP, Morrow D, et al. (2005) C-Reactive protein levels and outcomes after statin therapy. N Engl J Med 352:20–28PubMedCrossRef Ridker PM, Cannon CP, Morrow D, et al. (2005) C-Reactive protein levels and outcomes after statin therapy. N Engl J Med 352:20–28PubMedCrossRef
27.
Zurück zum Zitat Ridker PM, Hennekens CH, Buring JE, Rifai N (2000) C-Reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 342:836–843PubMedCrossRef Ridker PM, Hennekens CH, Buring JE, Rifai N (2000) C-Reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 342:836–843PubMedCrossRef
28.
Zurück zum Zitat Rutter Mk, Meigs JB, Sullivan LM, D’Agostina RB Sr, Wilson PW (2004) C-Reactive protein, the metabolic syndrome, and prediction of cardiovascular events in the Framingham offspring study. Circulation 110:380–385PubMedCrossRef Rutter Mk, Meigs JB, Sullivan LM, D’Agostina RB Sr, Wilson PW (2004) C-Reactive protein, the metabolic syndrome, and prediction of cardiovascular events in the Framingham offspring study. Circulation 110:380–385PubMedCrossRef
29.
Zurück zum Zitat Schwartz GJ, Haycock GB, Edelmann CM Jr, Spitzer A (1976) Predicting glomerular filtration rate in children derived from body length and plasma creatinine. Pediatrics 106:522–526 Schwartz GJ, Haycock GB, Edelmann CM Jr, Spitzer A (1976) Predicting glomerular filtration rate in children derived from body length and plasma creatinine. Pediatrics 106:522–526
30.
Zurück zum Zitat Sorof J, Alexandrov AV, Garami Z, Turner JL, Grafe RE, Lai DL (2003) Carotid ultrasonography for detection of vascular abnormalities in hypertensive children. Pediatr Nephrol 18:1020–1024PubMedCrossRef Sorof J, Alexandrov AV, Garami Z, Turner JL, Grafe RE, Lai DL (2003) Carotid ultrasonography for detection of vascular abnormalities in hypertensive children. Pediatr Nephrol 18:1020–1024PubMedCrossRef
31.
Zurück zum Zitat Stuveling EM, Hillege HL, Bakker SJL et al. PREVEND Study Group (2004) C-reactive protein and microalbuminuria differ in their associations with various domains of vascular disease. Atherosclerosis 172:107–114 Stuveling EM, Hillege HL, Bakker SJL et al. PREVEND Study Group (2004) C-reactive protein and microalbuminuria differ in their associations with various domains of vascular disease. Atherosclerosis 172:107–114
32.
Zurück zum Zitat Tsioufis C, Dimitriadis K, Chatzis D, et al. (2005) Relation of microalbuminuria to adiponectin and augmented C-reactive protein levels in man with essential hypertension. Am J Cardiol 96:946–951PubMedCrossRef Tsioufis C, Dimitriadis K, Chatzis D, et al. (2005) Relation of microalbuminuria to adiponectin and augmented C-reactive protein levels in man with essential hypertension. Am J Cardiol 96:946–951PubMedCrossRef
33.
Zurück zum Zitat Viberti G, Wheeldon NM (2002) Microalbuminuria reduction with valsartan in patients with type 2 diabetes mellitus: a blood pressure independent effect. Circulation 106:672–678PubMedCrossRef Viberti G, Wheeldon NM (2002) Microalbuminuria reduction with valsartan in patients with type 2 diabetes mellitus: a blood pressure independent effect. Circulation 106:672–678PubMedCrossRef
Metadaten
Titel
Relation of Left Ventricular Hypertrophy to Microalbuminuria and C-Reactive Protein in Children and Adolescents with Essential Hypertension
verfasst von
Farahnak Assadi
Publikationsdatum
01.05.2008
Verlag
Springer-Verlag
Erschienen in
Pediatric Cardiology / Ausgabe 3/2008
Print ISSN: 0172-0643
Elektronische ISSN: 1432-1971
DOI
https://doi.org/10.1007/s00246-007-9153-4

Weitere Artikel der Ausgabe 3/2008

Pediatric Cardiology 3/2008 Zur Ausgabe

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.